Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Waterloo

$25,000.00

Non-invasive drug delivery by phytospherix nanoparticles

EF 2016-17

Résumé
Phytospherix is a naturally occurring nanoparticle technology developed by Mirexus, an Ontario company. Our objective is toevaluate the suitability of Phytospherix technology for non-invasive (needle-free) drug delivery. Therapeutic effectiveness of drugsis hampered by the lack of alternative (non-injectable) dosage forms, physicochemical stability issues, low bioavailability, repeatedadministration and poor transfer across biological barriers. The emerging need for needle-free routes of administration, targeteddelivery and for delivery systems that are more biocompatible and easier to manufacture is fully recognized. Non-invasiveadministration methods, such as ocular, dermal, and pulmonary are highly sought after because they provide opportunities forimproving the bioavailability and pharmacokinetic profile of drugs, resulting in lower side effects, reduced frequency ofadministration and increased patient acceptance. In this project we will evaluate the properties of a series of chemically modifiedPhytosperix nanoparticles in order to correlate the physicochemical properties with the molecular requirements for optimuminteraction with the barrier layers of the eye, skin and lungs and determine the best candidates for drug delivery purposes.
Programme
Engage Grants Program
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
502058-2016
Name nom
Foldvari, Marianna
Department département
Pharmacy, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
Non-invasive drug delivery by phytospherix nanoparticles
Keyword
NSERC
Application summary
Phytospherix is a naturally occurring nanoparticle technology developed by Mirexus, an Ontario company. Our objective is toevaluate the suitability of Phytospherix technology for non-invasive (needle-free) drug delivery. Therapeutic effectiveness of drugsis hampered by the lack of alternative (non-injectable) dosage forms, physicochemical stability issues, low bioavailability, repeatedadministration and poor transfer across biological barriers. The emerging need for needle-free routes of administration, targeteddelivery and for delivery systems that are more biocompatible and easier to manufacture is fully recognized. Non-invasiveadministration methods, such as ocular, dermal, and pulmonary are highly sought after because they provide opportunities forimproving the bioavailability and pharmacokinetic profile of drugs, resulting in lower side effects, reduced frequency ofadministration and increased patient acceptance. In this project we will evaluate the properties of a series of chemically modifiedPhytosperix nanoparticles in order to correlate the physicochemical properties with the molecular requirements for optimuminteraction with the barrier layers of the eye, skin and lungs and determine the best candidates for drug delivery purposes.